|46.13||+0.1800||+0.39%||Vol 1.01M||1Y Perf -3.97%|
|Oct 5th, 2022 16:00 DELAYED|
|- -%||- -|
|Target Price||51.13||Analyst Rating||Moderate Buy 2.00|
|Potential %||10.84||Finscreener Ranking||★ 41.84|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★+ 43.50|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★+ 54.39|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★ 38.99|
|Price Range Ratio 52W %||51.68||Earnings Rating||Sell|
|Market Cap||8.46B||Earnings Date||9th Nov 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||9th Nov 2022|
|Estimated EPS Next Report||0.60|
|EPS Growth Next 5 Years %||12.10|
|Avg. Weekly Volume||858.56K|
|Avg. Monthly Volume||949.38K|
|Avg. Quarterly Volume||791.16K|
Genpact Limited (NYSE: G) stock closed at 46.13 per share at the end of the most recent trading day (a 0.39% change compared to the prior day closing price) with a volume of 1.01M shares and market capitalization of 8.46B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Software industry, Technology sector and employs 96300 people. Genpact Limited CEO is N. V. Tyagarajan.
The one-year performance of Genpact Limited stock is -3.97%, while year-to-date (YTD) performance is -13.09%. G stock has a five-year performance of 58.3%. Its 52-week range is between 37.68 and 54.03, which gives G stock a 52-week price range ratio of 51.68%
Genpact Limited currently has a PE ratio of 24.50, a price-to-book (PB) ratio of 4.59, a price-to-sale (PS) ratio of 2.54, a price to cashflow ratio of 18.80, a PEG ratio of 2.32, a ROA of 7.74%, a ROC of 10.21% and a ROE of 20.34%. The company’s profit margin is 7.52%, its EBITDA margin is 15.40%, and its revenue ttm is $3.23 Billion , which makes it $17.60 revenue per share.
Of the last four earnings reports from Genpact Limited, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.60 for the next earnings report. Genpact Limited’s next earnings report date is 09th Nov 2022.
The consensus rating of Wall Street analysts for Genpact Limited is Moderate Buy (2), with a target price of $51.13, which is +10.84% compared to the current price. The earnings rating for Genpact Limited stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Genpact Limited has a dividend yield of 1.12% with a dividend per share of $0.50 and a payout ratio of 25.00%.
Genpact Limited has a Buy technical analysis rating based on Technical Indicators (ADX : 6.61, ATR14 : 1.09, CCI20 : 70.48, Chaikin Money Flow : 0.06, MACD : -0.41, Money Flow Index : 61.97, ROC : 0.83, RSI : 60.78, STOCH (14,3) : 90.48, STOCH RSI : 1.00, UO : 55.03, Williams %R : -9.52), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Genpact Limited in the last 12-months were: Balkrishan Kalra (Sold 24 456 shares of value $1 162 808 ), Carol Lindstrom (Sold 2 409 shares of value $102 358 ), Heather D. White (Option Excercise at a value of $831 000), Heather D. White (Sold 38 315 shares of value $1 853 971 ), Kathryn A. Stein (Option Excercise at a value of $742 200), Kathryn A. Stein (Sold 45 000 shares of value $2 152 065 )
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.